Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The GRA Venture Fund is a private-public venture capital entity focused on financing early-stage technology and life sciences companies emerging from Georgia’s research universities. It aims to bridge the gap between academic research and commercial success by providing seed and early-stage capital to startups in biotechnology, medical devices, and digital health. The fund is a collaborative effort involving the Georgia Research Alliance, the State of Georgia, and private institutional investors. By supporting high-growth enterprises, the fund plays a critical role in expanding Georgia's bioscience and technology ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Georgia Biosciences Seed Capital Fund.